Skip to main navigation Skip to search Skip to main content

Cross-platform transcriptomic profiling of the response to recombinant human erythropoietin

  • Guan Wang*
  • , Traci Kitaoka
  • , Ali Crawford
  • , Qian Mao
  • , Andrew Hesketh
  • , Fergus Guppy
  • , Garrett I. Ash
  • , Jason Liu
  • , Mark Gerstein
  • , Yannis Pitsiladis
  • *Corresponding author for this work

    Research output: Contribution to journalJournal articlepeer-review

    8 Citations (Scopus)

    Abstract

    RNA-seq has matured and become an important tool for studying RNA biology. Here we compared two RNA-seq (MGI DNBSEQ and Illumina NextSeq 500) and two microarray platforms (GeneChip Human Transcriptome Array 2.0 and Illumina Expression BeadChip) in healthy individuals administered recombinant human erythropoietin for transcriptome-wide quantification of differential gene expression. The results show that total RNA DNB-seq generated a multitude of target genes compared to other platforms. Pathway enrichment analyses revealed genes correlate to not only erythropoiesis and oxygen transport but also a wide range of other functions, such as tissue protection and immune regulation. This study provides a knowledge base of genes relevant to EPO biology through cross-platform comparisons and validation.
    Original languageEnglish
    Article number21705
    JournalScientific Reports
    Volume11
    Issue number1
    DOIs
    Publication statusPublished - 4 Nov 2021

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Cross-platform transcriptomic profiling of the response to recombinant human erythropoietin'. Together they form a unique fingerprint.

    Cite this